Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Torlakovic

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 7, 2016
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 1: Fit-for-Purpose Approach to Classification of Clinical Immunohistochemistry BiomarkersCarol C Cheung, Corrado D'Arrigo, Manfred Dietel, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 10, 2017
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine - Part 2: Immunohistochemistry Test Performance CharacteristicsEmina E Torlakovic, Carol C Cheung, Corrado D'Arrigo, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 11, 2017
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine. Part 3: Technical Validation of Immunohistochemistry (IHC) Assays in Clinical IHC LaboratoriesEmina E Torlakovic, Carol C Cheung, Corrado D'Arrigo, et al.
American Journal of Clinical Pathology|October 17, 2014
Canadian Association of Pathologists-Association canadienne des pathologistes National Standards Committee for High Complexity Testing/Immunohistochemistry: guidelines for the preparation, release, and storage of unstained archived diagnostic tissue sections for immunohistochemistryCarol C Cheung, Diponkar Banerjee, Penny J Barnes, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 13, 2016
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 4: Tissue Tools for Quality Assurance in ImmunohistochemistryCarol C Cheung, Corrado D'Arrigo, Manfred Dietel, et al.
Current Oncology (Toronto, Ont.)|September 25, 2019
Crizotinib inhibition of <i>ROS1-</i>positive tumours in advanced non-small-cell lung cancer: a Canadian perspectiveD G Bebb, J Agulnik, R Albadine, et al.
Archives of Pathology & Laboratory Medicine|January 14, 2020
Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline UpdateKimberly H Allison, M Elizabeth H Hammond, Mitchell Dowsett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2020
Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline UpdateKimberly H Allison, M Elizabeth H Hammond, Mitchell Dowsett, et al.
Lung Cancer (Amsterdam, Netherlands)|September 11, 2021
Canadian ROS proto-oncogene 1 study (CROS) for multi-institutional implementation of ROS1 testing in non-small cell lung cancerCarol C Cheung, Adam C Smith, Roula Albadine, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 5, 2019
Fit-For-Purpose PD-L1 Biomarker Testing For Patient Selection in Immuno-Oncology: Guidelines For Clinical Laboratories From the Canadian Association of Pathologists-Association Canadienne Des Pathologistes (CAP-ACP)Carol C Cheung, Penny Barnes, Gilbert Bigras, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 7, 2016
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 1: Fit-for-Purpose Approach to Classification of Clinical Immunohistochemistry BiomarkersCarol C Cheung, Corrado D'Arrigo, Manfred Dietel, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 10, 2017
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine - Part 2: Immunohistochemistry Test Performance CharacteristicsEmina E Torlakovic, Carol C Cheung, Corrado D'Arrigo, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 11, 2017
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine. Part 3: Technical Validation of Immunohistochemistry (IHC) Assays in Clinical IHC LaboratoriesEmina E Torlakovic, Carol C Cheung, Corrado D'Arrigo, et al.
American Journal of Clinical Pathology|October 17, 2014
Canadian Association of Pathologists-Association canadienne des pathologistes National Standards Committee for High Complexity Testing/Immunohistochemistry: guidelines for the preparation, release, and storage of unstained archived diagnostic tissue sections for immunohistochemistryCarol C Cheung, Diponkar Banerjee, Penny J Barnes, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 13, 2016
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 4: Tissue Tools for Quality Assurance in ImmunohistochemistryCarol C Cheung, Corrado D'Arrigo, Manfred Dietel, et al.
Current Oncology (Toronto, Ont.)|September 25, 2019
Crizotinib inhibition of <i>ROS1-</i>positive tumours in advanced non-small-cell lung cancer: a Canadian perspectiveD G Bebb, J Agulnik, R Albadine, et al.
Archives of Pathology & Laboratory Medicine|January 14, 2020
Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline UpdateKimberly H Allison, M Elizabeth H Hammond, Mitchell Dowsett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2020
Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline UpdateKimberly H Allison, M Elizabeth H Hammond, Mitchell Dowsett, et al.
Lung Cancer (Amsterdam, Netherlands)|September 11, 2021
Canadian ROS proto-oncogene 1 study (CROS) for multi-institutional implementation of ROS1 testing in non-small cell lung cancerCarol C Cheung, Adam C Smith, Roula Albadine, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 5, 2019
Fit-For-Purpose PD-L1 Biomarker Testing For Patient Selection in Immuno-Oncology: Guidelines For Clinical Laboratories From the Canadian Association of Pathologists-Association Canadienne Des Pathologistes (CAP-ACP)Carol C Cheung, Penny Barnes, Gilbert Bigras, et al.
Pageof 8